New year, new option: Cyclo-Provera awaits word.
D000569:Americas; D003257:Consumer Product Safety; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D005193:Family Planning Services; D006077:Government Agencies; D007267:Injections; D019359:Knowledge; D017258:Medroxyprogesterone Acetate; D009656:North America; D009938:Organizations; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Usage; Developed Countries; Family Planning; Government Agencies; Injectables; Knowledge; Medroxyprogesterone Acetate; North America; Northern America; Organizations; Product Approval; United States; Usfda; Usphs